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Over 25 years ago seminal experi-
ments from the labs of Peter Jones and 
Harold Weintraub demonstrated that 
alteration in the DNA modification 
state underlie the myogenic conver-
sion of fibroblast cell lines [1, 2]. This 
paved the way for the identification 
of myogenic helix-loop-helix (HLH) 
proteins in muscle differentiation, but 
the mechanism by which DNA methy-
lation regulates muscle differentiation 
has remained elusive [3]. In general, 
DNA methylation at the 5′-position of 
cytosine (in CpG dinucleotides) is as-
sociated with transcriptional repression 
and implicated in maintaining patterns 
of gene expression between different 
cell types and during differentiation. 
How DNA methylation contributes to 
a gene regulatory network that directs 
spatial, temporal and ultimately lineage 
restricted patterns of gene expression in 
the developing embryo is still unclear. 
One proposed mechanism involves the 
binding of methyl-CpG-binding pro-
teins (MeCPs) to methylated DNA that 
can be viewed as ‘reading the mark’. 
Various protein domains have an affin-
ity for methylated cytosine including 
the methyl-binding domain (MBD) of 
MeCP2 and the zinc-finger domains 
of the Kaiso-like protein family [4]. 
MeCPs associate with heterochromatin 
in nuclei and recruit silencing complex-
es to reduce the transcription potential 
of methylated genes.
Genetic analysis of the four MBD-
containing proteins in mammals capable 
of binding methylated DNA: MeCP2, 
MBD1, MBD2 and MBD4, has not 
implicated them in muscle develop-
ment [4]. A second class of proteins, 
the Kaiso-like family of methyl-CpG-
binding proteins (Kaiso (ZBTB33), 
ZBTB4 and CIBZ (ZBTB38)), have 
also been associated with transcriptional 
repression of methylated reporter genes 
[5, 6]. However, in general, mice lack-
ing MeCPs display very minor or no 
developmental phenotypes [4], whereas 
mice lacking DNA methyltransferases, 
Dnmt1 or Dnmt3b, show severe de-
velopmental defects including reduced 
somite formation in the case of Dnmt1 
[7, 8]. This contrasts with Xenopus 
laevis, where xKaiso and xMeCP2 ap-
pear to have a more prominent role in 
embryonic development. Depletion of 
xMeCP2 in Xenopus embryos leads to 
altered neural patterning and embry-
onic lethality through mis-expression of 
another HLH factor, xHairy2a [9] and 
depletion of xKaiso leads to premature 
activation of zygotic transcription and 
embryonic lethality [10]. 
Recently, Oikawa et al. [11] ad-
vanced our understanding of a less well-
studied methyl-CpG-binding protein, 
CIBZ, by studying its role in muscle 
differentiation through regulation of 
Myogenin, a gene encoding a basic 
HLH protein that is an essential muscle-
specific transcription factor [12]. CIBZ 
(CtBP-interacting BTB zinc finger 
protein, ZBTB38) possesses a modified 
zinc finger domain capable of binding 
methylated DNA in vitro and can act as 
a transcriptional repressor of methylated 
reporter genes [5]. Satellite cells, one 
of the first discovered adult stem cell 
populations, are responsible for post-
natal muscle growth and regeneration 
following muscle damage. The major-
ity of satellite cells remain quiescent 
in adult muscle but upon stimulation 
re-enter the cell cycle and proliferate as 
myoblasts to repopulate the satellite cell 
pool and undergo myogenic differentia-
tion. Myogenin is activated early in this 
differentiation process and is one of the 
key transcription factors involved in 
coordinating myogenic differentiation. 
The Myogenin promoter in developing 
somites is initially methylated prior to 
activation and is subsequently dem-
ethylated [13]. The myoblast cell line 
C2C12 can be induced to differentiate 
to myotubes upon serum starvation and 
faithfully recapitulates the activation of 
Myogenin during differentiation. Using 
a combination of these cells and in vivo 
muscle regeneration assays, Oikawa et 
al. show that expression of CIBZ and 
Myogenin proteins are reciprocally reg-
ulated when satellite cells are induced to 
differentiate: CIBZ levels are attenuated 
while Myogenin levels increase. Further 
investigation showed that changes in 
Cell Research | Vol 21 No 11 | November 2011
1532
npg
Myogenin levels are attributable to an 
upregulation of the mRNA, whereas 
changes in CIBZ levels appear to be at 
the protein level, suggesting that it is 
directly implicated in Myogenin regu-
lation. Next, the authors show that the 
level of CIBZ protein is an important 
factor in myogenic differentiation, as 
manipulation of CIBZ levels in C2C12 
cells alters their propensity to undergo 
myogenesis in vitro. Specifically, reduc-
tion of CIBZ protein levels induced ec-
topic expression of Myogenin in C2C12 
cells and accelerated the formation of 
myotubes in vitro, whereas ectopically 
expressed CIBZ attenuated Myogenin 
upregulation upon differentiation. These 
reciprocal observations suggest that 
tight regulation of CIBZ levels are a key 
step in satellite cell differentiation. Im-
portantly, the Myogenin gene appears to 
be a direct target of the CIBZ protein in 
a DNA methylation-dependent manner 
in vitro and in vivo, and is capable of re-
pressing methylated Myogenin reporter 
constructs. Their data is in accordance 
with a model proposed by Joan Boyes 
and colleagues where DNA methyla-
tion helps to restrict Myogenin activa-
tion until both of its activation factors, 
MEF2A and SIX1, are co-expressed 
[13]. SIX1 is suggested to be required 
for demethylation and reorganization 
of chromatin at the promoter, leading 
to full expression. This model might 
also be applicable to the prevention of 
premature or inappropriate activation 
of a substantial number of other tissue-
specific genes with an intermediate 
density of methylated CpGs at their 
promoters.
In summary, this work shows that 
CIBZ is required to suppress myo-
genic differentiation in satellite cells 
in vitro, most likely due to its role in 
the transcriptional repression of the 
key myogenic differentiation factor 
Myogenin. This provides support for the 
hypothesis that ‘readers’ are required to 
interpret the DNA methylation signal in 
order to exert its function on transcrip-
tional repression (Figure 1). This study 
identifies an important selective target 
gene of methyl-CpG-binding proteins 
and suggests that they can play previ-
ously unappreciated and very specific 
roles in biological processes. As CIBZ 
expression is fairly ubiquitous, it will 
be interesting to uncover the wider role 
that this protein plays in gene repres-
sion, in addition to discovering more 
about its function in myogenesis, 
through constitutive and conditional 
mouse knockout studies. This study has 
also furthered our understanding of the 
molecular mechanisms that govern the 
maintenance and differentiation of an 
adult stem-cell population. In this re-
spect it will be interesting to learn more 
about the regulation of this mechanism 
in growth and regeneration of skeletal 
muscle in vivo, in particular the dynamic 
Figure 1 A model for Myogenin regulation during myogenesis. In undifferenti-
ated myoblasts the Myogenin promoter is DNA methylated and bound by CIBZ. 
This negatively influences the binding of myogenic transcription factors to the 
promoter and maintains repression of Myogenin. Upon induction of differentia-
tion the CIBZ protein is rapidly degraded and a reduction in DNA methylation at 
the promoter is observed, leading to increased binding of myogenic transcrip-
tion factors and expression of Myogenin. For simplicity only one CpG is shown. 
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regulation of the CIBZ protein during 
this process. Interestingly, in this regard, 
the ubiquitin-proteasome pathway has 
been linked to the rapid downregulation 
of CIBZ during myogenic differentia-
tion [14]. Further investigation may re-
veal the regulatory mechanisms behind 
differentiation of satellite cells and in 
the future lead to a better understanding 
of myodegenerative diseases. 
In light of previous studies of other 
methyl-CpG-binding proteins, the mu-
tation of which cause only relatively 
mild phenotypes, it may have seemed 
a tall order to some that CIBZ would 
have a key role in transcriptional repres-
sion during a cell differentiation pro-
cess. Coincidently, a single-nucleotide 
polymorphism in the human homolog 
of CIBZ, ZBTB38, was shown in a 
genome-wide association study to be 
the polymorphism most associated with 
human height [15]. The reason for this 
observation is unclear, but it is an inter-
esting speculation that polymorphisms 
of ZBTB38 in a population may con-
tribute to variation in human stature via 
a role in skeletal muscle differentiation 
and growth.
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